WisdomTree Global SmallCap Dividend Fund
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GSD research report →
Price Chart
About the company
This fund's core objective is to replicate the performance, encompassing both price movements and income generation, of the WisdomTree Global SmallCap Dividend Index. To achieve this, it allocates a minimum of 80% of its total capital to either the securities that make up this index or to other financial instruments that possess comparable economic attributes. The underlying index utilizes a fundamental weighting approach and is composed of smaller companies.
- CEO
- J. Richard Iler
- IPO
- 2021
- HQ
- New York, NY, US
Get TickerSpark's AI analysis on GSD
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $37.24M
- P/E
- -40.18
- PEG
- -0.04
- P/S
- 0.00
- P/B
- 0.31
- EV/EBITDA
- -20.58
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -0.76%
- ROIC
- -1.72%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $-1,859,845+0.0%
- Op Income
- $-1,859,845
- Net Income
- $-788,408-19.8%
- EPS
- $-0.28-201.4%
- OCF Growth
- -3.3%
- FCF Growth
- -3.3%
- 52W High
- $11.98
- 52W Low
- $9.90
- 50D MA
- $11.09
- 200D MA
- $10.96
- Beta
- 0.00
- RSI (14)
- 21
- Avg Volume
- 2.05K
No earnings-call transcripts are available for GSD yet.
- Free Float
- 0.0%
- Shares Outstanding
- 3.31M
- Float Shares
- 0
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 11, 23 | MIZUHO SECURITIES USA LLC | other | 0 |
| Aug 11, 23 | MIZUHO SECURITIES USA LLC | sell | 60,190 |
| Feb 7, 23 | Yakira Capital Management, Inc. | sell | 8,400 |
| Feb 8, 23 | Yakira Capital Management, Inc. | sell | 127,500 |
| Jan 31, 23 | Yakira Capital Management, Inc. | other | 0 |
| Oct 12, 22 | DarkPulse, Inc. | other | 2,623,120 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our GSD coverage
Recent articles, reports, and earnings notes.
No research on GSD yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate GSD report →Devonian Health Group Anticipates to Commence Trading on the NYSE American
prnewswire.com · Aug 18
Devonian Health Group Announces Proposed Listing on the NYSE American with Concurrent Underwritten Public Offering
prnewswire.com · Jul 27
Devonian Health Group Reports Financial and Operating Results of its Three and Nine Months Ended April 30, 2026
prnewswire.com · Jun 29
Devonian Health Group Inc. Reports Financial and Operating Results of its Three and Six Months Ended January 31, 2026
prnewswire.com · Mar 25
Devonian Reports Human Liver-on-a-Chip Data Demonstrating Disease-Relevant Modulation of MASH by Thykamine™, with Dose-Dependent Anti-Fibrotic and Anti-Inflammatory Effects
prnewswire.com · Feb 19
Devonian Advances Thykamine™ Patent Strategy with Proprietary Fingerprint and Robust Manufacturing Controls
prnewswire.com · Feb 17
Devonian reports additional molecular data from MASH liver study
prnewswire.com · Feb 12
DEVONIAN REPORTS POSITIVE RESULTS IN PULMONARY FIBROSIS STUDY
prnewswire.com · Feb 10
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.